An international team of researchers led by Lancaster University has made a promising breakthrough in the development of drugs to treat Alzheimer's Disease. For the first time, scientists have developed a drug that works on both major aggregation-promoting "hotspots" of the tau protein in the brain—a key driver of neurodegeneration.

Researchers from a study funded by the Alzheimer’s Society of UK have developed a new drug known as RI-AG03 that they say can prevent the build-up of toxic proteins in the brain that lead to neurodegenerative issues causing Alzheimer’s disease.

In a promising breakthrough, an international team of researchers from the UK, US, and Japan has developed a new Alzheimer's